MedPath

成都青山利康药业股份有限公司

Ownership
-
Established
2001-11-30
Employees
-
Market Cap
-
Website
www.qslk.net

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

59

NMPA:59

Drug Approvals

Roxadustat Capsules

Product Name
罗沙司他胶囊
Approval Number
国药准字H20253621
Approval Date
Mar 11, 2025
NMPA

Hemofiltration Replacement Fluid of Sodium Citrate

Product Name
枸橼酸钠血滤置换液
Approval Number
国药准字H20253505
Approval Date
Mar 4, 2025
NMPA

Calcium Gluconate and Sodium Chloride Injection

Product Name
葡萄糖酸钙氯化钠注射液
Approval Number
国药准字H20244381
Approval Date
Jul 9, 2024
NMPA

Calcium gluconate injection

Product Name
葡萄糖酸钙注射液
Approval Number
国药准字H20244396
Approval Date
Jul 9, 2024
NMPA

Low Calcium Peritoneal Dialysis Solution (Lactate-G1.5%)

Product Name
低钙腹膜透析液(乳酸盐-G1.5%)
Approval Number
国药准字H20193079
Approval Date
Nov 30, 2023
NMPA

Low Calcium Peritoneal Dialysis Solution (Lactate-G2.5%)

Product Name
低钙腹膜透析液(乳酸盐-G2.5%)
Approval Number
国药准字H20193072
Approval Date
Nov 30, 2023
NMPA

Low Calcium Peritoneal Dialysis Solution (Lactate-G4.25%)

Product Name
低钙腹膜透析液(乳酸盐-G4.25%)
Approval Number
国药准字H20193073
Approval Date
Nov 30, 2023
NMPA

Balanced Salt Solution Irrigating

Product Name
平衡盐溶液(供灌注用)
Approval Number
国药准字H20234378
Approval Date
Oct 27, 2023
NMPA

Balanced Salt Solution Irrigating

Product Name
平衡盐溶液(供灌注用)
Approval Number
国药准字H20234377
Approval Date
Oct 27, 2023
NMPA

心达康软胶囊

Approval Number
国药准字Z20080125
Approval Date
Dec 26, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.